Migraine Headache
Conditions
Interventions
• Study setting: Teaching Hospital, Anuradhapura.
• Randomization: 1:1 randomization using sealed envelopes.
• Treatment group: Dry needling for active trigger points in suboccipital, and cervical mus
Sponsors
University of Peradeniya
Eligibility
Inclusion criteria
Inclusion criteria: • Adult patients with migraine headache * Minimum age 18 and maximum age 50 years • Diagnosis should be confirmed by a consultant neurologist based on the International Classification of Headache Disorders (ICHD-3). • Patients should have at least one active trigger point in their suboccipital and cervical musculature.
Exclusion criteria
Exclusion criteria: • Patient with a history of neck trauma, cervical radiculopathy • Patients with previous surgery on the neck or shoulder area • Patients with abnormal bleeding tendencies, a severely compromised immune system, vascular disease • Frail patients, • Patients with epilepsy • Patient allergic to metals or latex • Patients with altered psychological status, • Patient with prosthetic implants, and implantable electrical devices. • Patients with a history of physiotherapy intervention in the neck and shoulder region in the previous six months • Pregnancy • Patients with needle phobia • Patients who are on anticoagulant therapy • Patients with thrombocytopenia and those with lymphedema in a specific area or limb.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache intensity and frequency will be measured by using visual analogue scale and headache diary. Headache frequency of the participants will be measured by maintaining a headache diary to record the number of headaches and duration (minutes/hours) per day in a week. Headache frequency is calculated as the weekly average for each subject as a primary outcome measure during the time frame of research conducts. [At the baseline, 1 week after the commencement of intervention, and at the end of 4 weeks] | — |
Secondary
| Measure | Time frame |
|---|---|
| Migraine-related disability and Quality of Life will be measured by using the Headache Impact Test (HIT) and Headache Disability Inventory questionnaires. Migraine-related disability will be measured by using the Migraine Disability Assessment (MIDAS) questionnaire in both treatment [At the baseline, end of the treatment protocol after one week of DN therapy, and 4 weeks after the intervention] | — |
Countries
Sri Lanka
Contacts
Public ContactH. M. M. D. Herath
Physiotherapist
Outcome results
None listed